ArticleBlood cancer journal2023

Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database.

A Visram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.